Research / NTRB / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-23-047881 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.55% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 46th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-157.23% · OPTIONAL · VALID
Revenue growth 23th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-0.21% · CORE · VALID
Inventory pressure 91th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.06% · OPTIONAL · VALID
Gross margin 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
46.61% · CORE · VALID
Operating margin 69th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
-213.42% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
83.96% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
15.73% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states History building
Oct 31, 2021 3/5 normalized Level 3 Jan 31, 2022 5/8 normalized Level 3 Apr 30, 2022 4/6 normalized Level 3 Jul 31, 2022 3/3 normalized Level 3 Oct 31, 2022 4/4 normalized Level 3 Jan 31, 2023 5/7 normalized Level 3 Apr 30, 2023 6/8 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 4/5 normalized Level 3 Jan 31, 2024 7/8 normalized Level 3 Apr 30, 2024 7/8 normalized Level 3 Jul 31, 2024 5/5 normalized Level 3 Oct 31, 2024 5/5 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 8/8 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 6/6 normalized Level 3 Period transition
What moved in the state? Capex Intensity Decreased
Previous 3.81%
Current 0.55%
Delta -3.26% Cash Generation Decreased
Previous -143.64%
Current -157.23%
Delta -13.58% Growth Decreased
Previous 46.23%
Current -0.21%
Delta -46.44% Inventory Pressure Increased
Previous 11.03%
Current 38.06%
Delta 27.03% Margin Increased
Previous 36.08%
Current 46.61%
Delta 10.52% Profitability Increased
Previous -215.19%
Current -213.42%
Delta 1.77% R And D Intensity Increased
Previous 47.23%
Current 83.96%
Delta 36.73% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.